Japanese based Taiko Pharmaceutical announced the results of tests of their patented long-lasting chlorine dioxide aqueous solution (JP5757975B2) for use in the fight against COVID-19. Their results concluded that their patented ClO2 solution defeated 99.99% of the SARS-CoV-2 as well as Alpha and Gamma COVID variants. The chlorine dioxide test was a joint effort between …